Home
About +
Our Science +
Investors +
Careers
Contact

Home
About
Our Science
Investors
Careers
Contact

Our Story
Meet the Team
FAQs

Inhaled IFN-β
Clinical Trials
Publications
Factsheets

Investor Overview
Investor News
Reports & Presentations
Major Shareholders & Advisers
Shareholder Information
Corporate Governance
TR-1/Options Press Release Archive

News

TR-1/Options Press Release Archive

Holding(s) in Company17th January 2025

Our Science
Interferon Beta
Investigating antiviral treatment in COVID-19
Prior studies investigating antiviral treatment in COPD
Prior studies investigating antiviral treatment in asthma
Relevant Publications
Factsheets

About
Home
Our Story
Team
FAQs
Careers
Contact

Investors
Investors Overview
Investor News
Reports & Presentations
Asset Match
Subscribe to news

Cookie Policy Legal Privacy Policy change

© Synairgen. All Rights ReservedRegistered in England and Wales No. 5233429 | Site by Ether